The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study
Authors:
- D.M. O»HanlonDOD.M. O»Hanlon
- R. McLaughlinRMR. McLaughlin
- T. McHaleTMT. McHale
- G.E. ConnollyGCG.E. Connolly
- H.F. GivenHGH.F. Given
- 1 September 2001
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (6) , 527-531
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CD44 Variant Isoform Expression and Breast Cancer PrognosisJapanese Journal of Cancer Research, 1998
- Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7–8 in human breast cancerEuropean Journal of Cancer, 1996
- A CD44 variant exon 6 epitope as a prognostic indicator in breast cancerEuropean Journal of Surgical Oncology, 1996
- Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potentialJournal of Cellular Physiology, 1994
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- CD44 and cancerThe Lancet, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein familyCell, 1989
- Homing Receptors and the Control of Lymphocyte MigrationImmunological Reviews, 1986